| Cancer stem cell in breast cancer therapeutic resistance X Bai, J Ni, J Beretov, P Graham, Y Li Cancer treatment reviews 69, 152-163, 2018 | 249 | 2018 |
| Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell … J Deng, X Bai, X Feng, J Ni, J Beretov, P Graham, Y Li BMC cancer 19, 1-12, 2019 | 190 | 2019 |
| Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters X Bai, Y Chen, X Hou, M Huang, J Jin Drug metabolism reviews 48 (4), 541-567, 2016 | 156 | 2016 |
| Exosomes and breast cancer drug resistance X Dong, X Bai, J Ni, H Zhang, W Duan, P Graham, Y Li Cell death & disease 11 (11), 987, 2020 | 128 | 2020 |
| Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel? X Bai, J Ni, J Beretov, P Graham, Y Li Cancer letters 497, 100-111, 2021 | 127 | 2021 |
| Sesamin enhances Nrf2-mediated protective defense against oxidative stress and inflammation in colitis via AKT and ERK activation X Bai, X Gou, P Cai, C Xu, L Cao, Z Zhao, M Huang, J Jin Oxidative Medicine and Cellular Longevity 2019, 2019 | 91 | 2019 |
| Cryptotanshinone reverses cisplatin resistance of human lung carcinoma A549 cells through down-regulating Nrf2 pathway C Xia, X Bai, X Hou, X Gou, Y Wang, H Zeng, M Huang, J Jin Cellular Physiology and Biochemistry 37 (2), 816-824, 2015 | 61 | 2015 |
| Cancer stem cells in prostate cancer radioresistance T Tsao, J Beretov, J Ni, X Bai, J Bucci, P Graham, Y Li Cancer letters 465, 94-104, 2019 | 60 | 2019 |
| Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis X Bai, W Hong, P Cai, Y Chen, C Xu, D Cao, W Yu, Z Zhao, M Huang, ... Toxicology and Applied Pharmacology 324, 12-25, 2017 | 39 | 2017 |
| Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis X Bai, J Ni, J Beretov, VC Wasinger, S Wang, Y Zhu, P Graham, Y Li Redox Biology 43, 101993, 2021 | 36 | 2021 |
| 3′, 4′, 5′, 5, 7-pentamethoxyflavone sensitizes Cisplatin-resistant A549 cells to Cisplatin by inhibition of Nrf2 pathway X Hou, X Bai, X Gou, H Zeng, C Xia, W Zhuang, X Chen, Z Zhao, M Huang, ... Molecules and cells 38 (5), 396-401, 2015 | 33 | 2015 |
| Immunotherapy for triple-negative breast cancer: a molecular insight into the microenvironment, treatment, and resistance X Bai, J Ni, J Beretov, P Graham, Y Li Journal of the National Cancer Center 1 (3), 75-87, 2021 | 31 | 2021 |
| Cryptotanshinone strengthens the effect of gefitinib against non-small cell lung cancer through inhibiting transketolase L Cao, W Hong, P Cai, C Xu, X Bai, Z Zhao, M Huang, J Jin European journal of pharmacology 890, 173647, 2021 | 22 | 2021 |
| THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple‐Negative Breast Cancer X Bai, J Ni, J Beretov, S Wang, X Dong, P Graham, Y Li Advanced Science 8 (24), 2102658, 2021 | 21 | 2021 |
| Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients X Bai, C Xu, D Wen, Y Chen, H Li, X Wang, L Zhou, M Huang, J Jin Psychopharmacology 235, 2665-2673, 2018 | 18 | 2018 |
| Simultaneous determination of seven taxoids in rat plasma by UPLC–MS/MS and pharmacokinetic study after oral administration of Taxus yunnanensis extracts B Liu, X Gou, X Bai, X Hou, D Li, G Zhong, J Jin, M Huang Journal of Pharmaceutical and Biomedical Analysis 107, 346-354, 2015 | 14 | 2015 |
| Postoperative adjuvant chemotherapy improved the prognosis in locally advanced cervical cancer patients with optimal response to neoadjuvant chemotherapy X Feng, H Chen, L Li, L Gao, L Wang, X Bai Frontiers in Oncology 10, 608333, 2020 | 10 | 2020 |
| CHTOP in chemoresistant epithelial ovarian cancer: a novel and potential therapeutic target X Feng, X Bai, J Ni, VC Wasinger, J Beretov, Y Zhu, P Graham, Y Li Frontiers in Oncology 9, 557, 2019 | 10 | 2019 |
| Chromatin target of protein arginine methyltransferase regulates invasion, chemoresistance, and stemness in epithelial ovarian cancer X Feng, L Li, L Wang, S Luo, X Bai Bioscience Reports 39 (4), BSR20190016, 2019 | 5 | 2019 |
| Tanshinone IIA acts as a regulator of lipogenesis to overcome osimertinib acquired resistance in lung cancer L Cao, Z Qin, T Yu, X Bai, S Jiang, D Wang, F Ning, M Huang, J Jin Biochemical Pharmacology 224, 116207, 2024 | | 2024 |
Professor Yong LiUNSW, Head of Cancer Research TeamVerified email at unsw.edu.au
